Akebia Therapeutics Inc
(STU:AX9)
€
3.382
+0.13 (+3.93%)
Market Cap: 897.21 Mil
Enterprise Value: 846.75 Mil
PE Ratio: 0
PB Ratio: 41.91
GF Score: 49/100 Akebia Therapeutics Inc (STU:AX9) Transcripts
- 1